Published in PLoS One on February 26, 2009
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest (2011) 3.23
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes (2012) 2.62
Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation (2012) 2.51
Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol (2012) 2.39
Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics (2009) 2.21
Nutritional metabolomics: progress in addressing complexity in diet and health. Annu Rev Nutr (2012) 1.89
LC-MS-based metabolomics. Mol Biosyst (2011) 1.36
Metabolite profiles during oral glucose challenge. Diabetes (2013) 1.31
Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics (2010) 1.24
Molecular nutrition research: the modern way of performing nutritional science. Nutrients (2012) 1.18
Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin. PLoS One (2014) 1.09
Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics (2011) 1.06
Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus. Evid Based Complement Alternat Med (2012) 1.03
Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes Nutr (2014) 0.94
Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice. PLoS One (2013) 0.92
Novel metabolic markers for the risk of diabetes development in American Indians. Diabetes Care (2014) 0.92
Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One (2010) 0.90
Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial. PLoS One (2012) 0.90
Toward metabolomic signatures of cardiovascular disease. Circ Cardiovasc Genet (2010) 0.90
Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC Med Genomics (2010) 0.89
Metabolome and fecal microbiota in monozygotic twin pairs discordant for weight: a Big Mac challenge. FASEB J (2014) 0.87
Phenotypic flexibility as a measure of health: the optimal nutritional stress response test. Genes Nutr (2015) 0.82
Perspective: a systems approach to diabetes research. Front Genet (2013) 0.82
Personalized metabolomics for predicting glucose tolerance changes in sedentary women after high-intensity interval training. Sci Rep (2014) 0.82
Lipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP mice. PLoS One (2012) 0.80
Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability. Br J Nutr (2012) 0.79
Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice. PLoS One (2011) 0.78
Metabolomics reveals unexpected responses to oral glucose. Diabetes (2013) 0.77
Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes. Metabolomics (2016) 0.76
Glucose prediction by analysis of exhaled metabolites - a systematic review. BMC Anesthesiol (2014) 0.76
Gut microbiota from metabolic disease-resistant, macrophage-specific RIP140 knockdown mice improves metabolic phenotype and gastrointestinal integrity. Sci Rep (2016) 0.75
The impact of micronutrient status on health: correlation network analysis to understand the role of micronutrients in metabolic-inflammatory processes regulating homeostasis and phenotypic flexibility. Genes Nutr (2017) 0.75
Crossing the Boundaries of Our Current Healthcare System by Integrating Ultra-Weak Photon Emissions with Metabolomics. Front Physiol (2016) 0.75
Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats. Oncol Lett (2014) 0.75
Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial. Front Immunol (2017) 0.75
Insulin induces a shift in lipid and primary carbon metabolites in a model of fasting-induced insulin resistance. Metabolomics (2017) 0.75
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78
Glutathione metabolism and its implications for health. J Nutr (2004) 6.27
A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2005) 4.95
Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol (2008) 3.82
The importance of glutathione in human disease. Biomed Pharmacother (2003) 3.61
Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol (2008) 3.48
Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem (2006) 3.24
Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med (2005) 2.98
Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci (2001) 2.51
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) (2004) 2.13
Microbial metabolomics with gas chromatography/mass spectrometry. Anal Chem (2006) 2.02
Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol (2007) 2.01
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol (2004) 1.86
Three-way component analysis: principles and illustrative application. Psychol Methods (2001) 1.58
Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos (2004) 1.51
Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension (2004) 1.38
Hyperuricemia and associated diseases. Rheum Dis Clin North Am (2006) 1.37
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol (2003) 1.35
The art and practice of systems biology in medicine: mapping patterns of relationships. J Proteome Res (2007) 1.35
A prospective study of weight change and systemic inflammation over 9 y. Am J Clin Nutr (2008) 1.32
Regulation of glutathione synthesis. Curr Top Cell Regul (2000) 1.31
Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev (2007) 1.17
Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS (2004) 1.13
Biomarkers of outcome from cardiovascular disease. Curr Opin Crit Care (2006) 1.05
Validation of biomarkers as early predictors of disease. Mutat Res (2001) 1.03
Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am J Physiol Endocrinol Metab (2002) 0.99
Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination with multivariate data analysis. Int Immunopharmacol (2004) 0.98
Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol (2004) 0.98
Translating genomic biomarkers into clinically useful diagnostics. Expert Rev Mol Diagn (2006) 0.93
Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions. Chem Res Toxicol (1998) 0.92
Role of monocarboxylic acid transporters in the cellular uptake of NSAIDs. J Pharm Pharmacol (2005) 0.88
Genomic approach to biomarker identification and its recent applications. Cancer Biomark (2006) 0.86
Towards a systems level analysis of health and nutrition. Curr Opin Biotechnol (2008) 0.85
Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen. Chem Res Toxicol (1997) 0.82
In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3beta-glucuronidation in human liver microsomes. Biopharm Drug Dispos (2005) 0.80
Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary. Pharmacogenomics J (2006) 0.80
Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine. Drug Metab Dispos (2002) 0.80
Effect of celecoxib, a cyclooxygenase-2-specific inhibitor, on insulin sensitivity, C-reactive protein, homocysteine, and metabolic profile in overweight or obese subjects. Metab Syndr Relat Disord (2005) 0.79
Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics (2006) 5.04
Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem (2006) 3.24
Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care (2005) 3.19
Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 2.90
Establishing reporting standards for metabolomic and metabonomic studies: a call for participation. OMICS (2006) 2.72
The metabolomics standards initiative. Nat Biotechnol (2007) 2.54
Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med (2007) 2.30
ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data. Bioinformatics (2005) 2.25
Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care (2004) 2.24
Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics (2009) 2.21
Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr (2006) 2.10
Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr (2005) 1.85
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol (2007) 1.80
Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol (2009) 1.64
Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One (2010) 1.64
The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol (2002) 1.60
Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics (2009) 1.58
Biomarkers of satiation and satiety. Am J Clin Nutr (2004) 1.56
Analysis of longitudinal metabolomics data. Bioinformatics (2004) 1.54
Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics (2011) 1.51
Quantitative analysis of target components by comprehensive two-dimensional gas chromatography. J Chromatogr A (2003) 1.50
Discovering gene expression patterns in time course microarray experiments by ANOVA-SCA. Bioinformatics (2007) 1.50
Assessing the statistical validity of proteomics based biomarkers. Anal Chim Acta (2007) 1.49
Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J Proteome Res (2009) 1.48
Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res (2005) 1.45
Multilevel data analysis of a crossover designed human nutritional intervention study. J Proteome Res (2008) 1.45
RPLC-ion-trap-FTMS method for lipid profiling of plasma: method validation and application to p53 mutant mouse model. J Proteome Res (2008) 1.40
Phenotype characterisation using integrated gene transcript, protein and metabolite profiling. Appl Bioinformatics (2004) 1.38
Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol (2009) 1.36
Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A (2010) 1.34
An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr (2010) 1.27
Primer on medical genomics. Part XIV: Introduction to systems biology--a new approach to understanding disease and treatment. Mayo Clin Proc (2004) 1.27
Kinetic energy density and agglomerate abrasion rate during blending of agglomerates into powders. Eur J Pharm Sci (2011) 1.25
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis (2011) 1.25
Analytical strategies in lipidomics and applications in disease biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.24
Exploring the benefits and challenges of establishing a DRI-like process for bioactives. Eur J Nutr (2014) 1.24
Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program. PLoS One (2009) 1.24
The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr (2005) 1.24
Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives. Metabolomics (2010) 1.21
Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes Nutr (2010) 1.18
Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput Biol (2009) 1.18
A classification model for the Leiden proteomics competition. Stat Appl Genet Mol Biol (2008) 1.16
Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease. Acta Paediatr Suppl (2008) 1.15
Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol (2004) 1.15
Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Rev Proteomics (2005) 1.14
Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol (2002) 1.14
Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr (2003) 1.13
Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS (2004) 1.13
Correlation network analysis for data integration and biomarker selection. Mol Biosyst (2008) 1.12
Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. Biochem Pharmacol (2003) 1.10
Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol (2007) 1.09
Ghrelin response to carbohydrate-enriched breakfast is related to insulin. Am J Clin Nutr (2005) 1.09
Alkaloid profiling of the Chinese herbal medicine Fuzi by combination of matrix-assisted laser desorption ionization mass spectrometry with liquid chromatography-mass spectrometry. J Chromatogr A (2008) 1.09
Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women. Diabetes Care (2008) 1.08
Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model. OMICS (2004) 1.08
How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Proteomics (2007) 1.07
Bromobenzene-induced hepatotoxicity at the transcriptome level. Toxicol Sci (2004) 1.07
Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics (2011) 1.06
Recent methodology in the phytochemical analysis of ginseng. Phytochem Anal (2008) 1.06
Alcohol consumption and risk of type 2 diabetes among older women. Diabetes Care (2005) 1.06
The Micronutrient Genomics Project: a community-driven knowledge base for micronutrient research. Genes Nutr (2010) 1.06
Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxicol Pathol (2005) 1.06
Comparative transcriptional profiling and preliminary study on heterosis mechanism of super-hybrid rice. Mol Plant (2010) 1.05
Human metabolomics: strategies to understand biology. Curr Opin Chem Biol (2013) 1.05
Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs. J Nutr (2003) 1.05
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol (2004) 1.04
The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women. Lipids Health Dis (2008) 1.04
Optimized time alignment algorithm for LC-MS data: correlation optimized warping using component detection algorithm-selected mass chromatograms. Anal Chem (2008) 1.04
Analyzing longitudinal microbial metabolomics data. J Proteome Res (2009) 1.04
Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta (2003) 1.03
Performance optimization of spectroscopic process analyzers. Anal Chem (2004) 1.02
Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J Ethnopharmacol (2009) 1.01
Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. J Proteome Res (2009) 1.01
Time alignment algorithms based on selected mass traces for complex LC-MS data. J Proteome Res (2010) 1.00
Effects of growth conditions and processing on Rehmannia glutinosa using fingerprint strategy. Planta Med (2006) 1.00
Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res (2002) 1.00
The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity (Silver Spring) (2006) 1.00
26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition (2011) 0.99
The photographer and the greenhouse: how to analyse plant metabolomics data. Phytochem Anal (2009) 0.99
Bioavailability and metabolism. Mol Aspects Med (2002) 0.99
Statistical data processing in clinical proteomics. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.99